Public trial
RBR-658khm Telemedicine in the Covid-19 pandemic in Brazil in a medical clinic in the supplementary health sector in São Paulo,…
Date of registration: 04/22/2020 (mm/dd/yyyy)Last approval date : 04/22/2020 (mm/dd/yyyy)
Study type:
Interventional
Scientific title:
en
Evaluation of patients treated by telemedicine in the Covid-19 pandemic in Brazil in a medical clinic in the supplementary health sector in São Paulo, Brazil
pt-br
Avaliação de pacientes atendidos por telemedicina na pandemia do Covid-19 no Brasil numa clínica médica do setor suplementar de saúde de São Paulo, Brasil
Trial identification
- UTN code: A36899523876
-
Public title:
en
Telemedicine in the Covid-19 pandemic in Brazil in a medical clinic in the supplementary health sector in São Paulo, Brazil
pt-br
Telemedicina na pandemia do Covid-19 no Brasil numa clínica médica do setor suplementar de saúde de São Paulo, Brasil
-
Scientific acronym:
-
Public acronym:
-
Secondaries identifiers:
-
30246520.0.0000.0069
Issuing authority: Plataforma Brasil
-
3.947.259
Issuing authority: Comitê de Ética em Pesquisa do Centro de Referência da Saúde da Mulher
-
30246520.0.0000.0069
Sponsors
- Primary sponsor: Centro Medico Mazzei
-
Secondary sponsor:
- Institution: Centro Medico Mazzei
-
Supporting source:
- Institution: Centro Medico Mazzei
Health conditions
-
Health conditions:
en
Covid-19; 2019-CoV; SARS-CoV; Telemedicine; Hydroxychloroquine
pt-br
Covid-19; 2019-CoV; SARS-CoV; Telemedicina; Hidroxicloroquina
-
General descriptors for health conditions:
en
C02 Virus diseases
pt-br
C02 Viroses
es
C02 Virosis
-
Specific descriptors:
Interventions
-
Interventions:
en
Initial sample size 90 people, which was divided into four groups Group 1: Asymptomatic patients, no drug intervention was performed Group 2: Patients with mild symptoms did not undergo any specific drug intervention Group 3: Patients with moderate symptoms were prescribed hydroxychloroquine associated with azithromycin Group 4: Serious patients referred to hospital treatment
pt-br
Tamanho inicial da amostra 90 pessoas, que foi dividida em quatros grupos Grupo 1: Pacientes assintomáticos não foi realizada intervenção medicamentosa Grupo 2: Pacientes com sintomas leves não foi realizada intervenção medicamentosa específica Grupo 3: Pacientes com sintomas moderados foi prescrita a medicação hidroxicloroquina associada ao medicamento azitromicina Grupo 4: Pacientes graves encaminhados ao tratamento hospitalar
-
Descriptors:
en
D03.633.100.810.050.180 Chloroquine
pt-br
D03.633.100.810.050.180 Cloroquina
es
D03.633.100.810.050.180 Cloroquina
en
D03.633.100.810.050.180.350 Hydroxychloroquine
pt-br
D03.633.100.810.050.180.350 Hidroxicloroquina
es
D03.633.100.810.050.180.350 Hidroxicloroquina
en
D02.540.576.500.992.050 Azithromycin
pt-br
D02.540.576.500.992.050 Azitromicina
es
D02.540.576.500.992.050 Azitromicina
Recruitment
- Study status: Recruiting
-
Countries
- Brazil
- Date first enrollment: 04/01/2020 (mm/dd/yyyy)
- Date last enrollment: 12/01/2020 (mm/dd/yyyy)
-
Target sample size: Gender: Minimum age: Maximum age: 90 - 0 - 0 - -
Inclusion criteria:
en
Patients with clinical and epidemiological diagnosis of covid-19 with moderate condition and possible poor prognosis without comorbidities that prevent home treatment.
pt-br
Pacientes com diagnóstico clínico e epidemiológico de covid-19 com quadro moderado e possível mau prognóstico sem comorbidades que impeçam o tratamento domiciliar.
-
Exclusion criteria:
en
Do not sign the informed consent form. Present previous heart disease / arrhythmia or associated comorbidity that requires hospital follow-up.
pt-br
Não assinar o termo de consentimento livre e esclarecido. Apresentar cardiopatia/ arritmia prévia ou comorbidade associada que necessite de acompanhamento hospitalar.
Study type
-
Study design:
-
Expanded access program Purpose Intervention assignment Number of arms Masking type Allocation Study phase Treatment Parallel 4 Open Non-randomized-controlled N/A
Outcomes
-
Primary outcomes:
en
Better results with reduced morbidity and mortality with treatment proposed by telemedicine, score of clinical improvement of patients who followed the drug protocol.
pt-br
Melhores resultados com diminuição da morbimortalidade com tratamento proposto por telemedicina, escore de melhora clínica dos pacientes que seguiram o protocolo medicamentoso.
-
Secondary outcomes:
en
Analysis of population, symptomatological and epidemiological characteristics related to Covid-19. Analysis of the therapeutic approach by telemedicine.
pt-br
Análise das características populacionais, sintomatológicas e epidemiológicas relacionadas ao Covid-19. Análise da abordagem terapêutica por telemedicina.
Contacts
-
Public contact
- Full name: Michelle Chechter
-
- Address: Av. Mazzei, 289
- City: São Paulo / Brazil
- Zip code: 02436070
- Phone: +5511994941748
- Email: mchechter@hotmail.com
- Affiliation: Centro Medico Mazzei
-
Scientific contact
- Full name: Michelle Chechter
-
- Address: Av. Mazzei, 289
- City: São Paulo / Brazil
- Zip code: 02436070
- Phone: +5511994941748
- Email: mchechter@hotmail.com
- Affiliation: Centro Medico Mazzei
-
Site contact
- Full name: Michelle Chechter
-
- Address: Av. Mazzei, 289
- City: São Paulo / Brazil
- Zip code: 02436070
- Phone: +5511994941748
- Email: mchechter@hotmail.com
- Affiliation: Centro Medico Mazzei
Additional links:
Total de Ensaios Clínicos 16949.
Existem 8346 ensaios clínicos registrados.
Existem 4699 ensaios clínicos recrutando.
Existem 235 ensaios clínicos em análise.
Existem 5767 ensaios clínicos em rascunho.